Herein, this study demonstrated that LncRNA RASAL2-AS1 was notably highly expressed in both Cal-27 and SCC-25 cells and HNSCC, and augmented RASAL2-AS1 was proven to accelerate HNSCC progression and benefit for clinical diagnosis. The gene discussed is RASAL2; the disease is head and neck squamous cell carcinoma.